Information

Tamiflu-resistant pandemic influenza H1N1 virus selected by prophylaxis

The emergence of oseltamivir (Tamiflu)-resistant 2009 H1N1 influenza virus in a Canadian family illustrates the basic concept that viral loads depend on the dose of antiviral drug. Neuraminidase inhibitors like Tamiflu and Relenza are used to treat severe illness caused by the 2009 pandemic influenza A (H1N1) virus. The antiviral drugs may also be used …

Tamiflu-resistant pandemic influenza H1N1 virus selected by prophylaxis Read More »

GlaxoSmithKline influenza H1N1 vaccine approved

GlaxoSmithKline’s inactivated 2009 influenza H1N1 vaccine has been approved by the US Food & Drug Administration and by Health Canada. This action completes the list of pandemic H1N1 vaccines which I previously summarized for the US and Canada. Influenza A (H1N1) 2009 monovalent vaccine is produced by ID Biomedical Corporation of Quebec, a wholly-owned subsidiary …

GlaxoSmithKline influenza H1N1 vaccine approved Read More »

Influenza virus is infectious for days on banknotes

Influenza virus may be transmitted among humans in three ways: by direct contact with infected individuals; by contact with contaminated objects (called fomites, such as toys, doorknobs); and by inhalation of virus-laden aerosols. The contribution of each mode to overall transmission of influenza is not known. But something that most of us touch on a …

Influenza virus is infectious for days on banknotes Read More »

Being older is a good defense against 2009 H1N1 influenza virus

Why is the incidence of infection with 2009 H1N1 influenza highest among 5-24 year olds, and lowest in those over 65 years of age? Were the oldsters previously infected with a related influenza virus, or is there another explanation? The sera of individuals born in the early part of the 20th century have antibodies that …

Being older is a good defense against 2009 H1N1 influenza virus Read More »

Scroll to Top